#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Assessing gut microbiota composition is currently relatively simple due to recent developments in DNA sequencing techniques .
2-1	16-25	Assessing	_	_	_	_
2-2	26-29	gut	abstract|substance[3]|abstract[4]	new|new[3]|new[4]	coref|coref|coref	3-7[10_4]|3-10|3-10[12_3]
2-3	30-40	microbiota	substance[3]|abstract[4]	new[3]|new[4]	_	_
2-4	41-52	composition	abstract[4]	new[4]	_	_
2-5	53-55	is	_	_	_	_
2-6	56-65	currently	_	_	_	_
2-7	66-76	relatively	_	_	_	_
2-8	77-83	simple	_	_	_	_
2-9	84-87	due	_	_	_	_
2-10	88-90	to	_	_	_	_
2-11	91-97	recent	abstract[5]	new[5]	_	_
2-12	98-110	developments	abstract[5]	new[5]	_	_
2-13	111-113	in	abstract[5]	new[5]	_	_
2-14	114-117	DNA	abstract[5]|abstract|abstract[7]|abstract[8]	new[5]|new|new[7]|new[8]	coref	8-20[68_7]
2-15	118-128	sequencing	abstract[5]|abstract[7]|abstract[8]	new[5]|new[7]|new[8]	_	_
2-16	129-139	techniques	abstract[5]|abstract[8]	new[5]|new[8]	_	_
2-17	140-141	.	_	_	_	_

#Text=Consequently , various studies have associated the composition of gut microbiota with age , disease or behaviour .
3-1	142-154	Consequently	_	_	_	_
3-2	155-156	,	_	_	_	_
3-3	157-164	various	abstract[9]	new[9]	coref	4-12[17_9]
3-4	165-172	studies	abstract[9]	new[9]	_	_
3-5	173-177	have	_	_	_	_
3-6	178-188	associated	_	_	_	_
3-7	189-192	the	abstract[10]	giv[10]	coref	4-31[24_10]
3-8	193-204	composition	abstract[10]	giv[10]	_	_
3-9	205-207	of	abstract[10]	giv[10]	_	_
3-10	208-211	gut	abstract[10]|abstract|substance[12]	giv[10]|giv|giv[12]	coref|coref	4-31[0_12]|5-20
3-11	212-222	microbiota	abstract[10]|substance[12]	giv[10]|giv[12]	_	_
3-12	223-227	with	_	_	_	_
3-13	228-231	age	abstract	new	_	_
3-14	232-233	,	_	_	_	_
3-15	234-241	disease	abstract	new	_	_
3-16	242-244	or	_	_	_	_
3-17	245-254	behaviour	abstract	new	_	_
3-18	255-256	.	_	_	_	_

#Text=However , the vast majority of published data are based on epidemiological studies and correlation analyses , which may not necessarily prove the causative link between the tested intervention , microbiota composition and host response .
4-1	257-264	However	_	_	_	_
4-2	265-266	,	_	_	_	_
4-3	267-270	the	abstract[16]	new[16]	coref	17-3[146_16]
4-4	271-275	vast	abstract[16]	new[16]	_	_
4-5	276-284	majority	abstract[16]	new[16]	_	_
4-6	285-287	of	abstract[16]	new[16]	_	_
4-7	288-297	published	abstract[16]	new[16]	_	_
4-8	298-302	data	abstract[16]	new[16]	_	_
4-9	303-306	are	_	_	_	_
4-10	307-312	based	_	_	_	_
4-11	313-315	on	_	_	_	_
4-12	316-331	epidemiological	abstract[17]|abstract[18]	giv[17]|giv[18]	coref|coref	4-12[18_17]|11-1[85_18]
4-13	332-339	studies	abstract[17]|abstract[18]	giv[17]|giv[18]	_	_
4-14	340-343	and	abstract[18]	giv[18]	_	_
4-15	344-355	correlation	abstract[18]|abstract|abstract[20]	giv[18]|new|new[20]	coref|coref	5-5|13-8[102_20]
4-16	356-364	analyses	abstract[18]|abstract[20]	giv[18]|new[20]	_	_
4-17	365-366	,	abstract[18]|abstract[20]	giv[18]|new[20]	_	_
4-18	367-372	which	abstract[18]|abstract[20]	giv[18]|new[20]	_	_
4-19	373-376	may	abstract[18]|abstract[20]	giv[18]|new[20]	_	_
4-20	377-380	not	abstract[18]|abstract[20]	giv[18]|new[20]	_	_
4-21	381-392	necessarily	abstract[18]|abstract[20]	giv[18]|new[20]	_	_
4-22	393-398	prove	abstract[18]|abstract[20]	giv[18]|new[20]	_	_
4-23	399-402	the	abstract[18]|abstract[20]|abstract[21]	giv[18]|new[20]|new[21]	_	_
4-24	403-412	causative	abstract[18]|abstract[20]|abstract[21]	giv[18]|new[20]|new[21]	_	_
4-25	413-417	link	abstract[18]|abstract[20]|abstract[21]	giv[18]|new[20]|new[21]	_	_
4-26	418-425	between	abstract[18]|abstract[20]|abstract[21]	giv[18]|new[20]|new[21]	_	_
4-27	426-429	the	abstract[18]|abstract[20]|abstract[21]|event[22]	giv[18]|new[20]|new[21]|new[22]	_	_
4-28	430-436	tested	abstract[18]|abstract[20]|abstract[21]|event[22]	giv[18]|new[20]|new[21]|new[22]	_	_
4-29	437-449	intervention	abstract[18]|abstract[20]|abstract[21]|event[22]	giv[18]|new[20]|new[21]|new[22]	_	_
4-30	450-451	,	abstract[18]|abstract[20]|abstract[21]	giv[18]|new[20]|new[21]	_	_
4-31	452-462	microbiota	abstract[18]|abstract[20]|abstract[21]|substance|abstract[24]	giv[18]|new[20]|new[21]|giv|giv[24]	coref|coref	5-21|11-9[87_24]
4-32	463-474	composition	abstract[18]|abstract[20]|abstract[21]|abstract[24]	giv[18]|new[20]|new[21]|giv[24]	_	_
4-33	475-478	and	abstract[18]|abstract[20]|abstract[21]	giv[18]|new[20]|new[21]	_	_
4-34	479-483	host	abstract[18]|abstract[20]|abstract[21]|animal|abstract[26]	giv[18]|new[20]|new[21]|new|new[26]	_	_
4-35	484-492	response	abstract[18]|abstract[20]|abstract[21]|abstract[26]	giv[18]|new[20]|new[21]|new[26]	_	_
4-36	493-494	.	_	_	_	_

#Text=In addition , the correlation analysis cannot distinguish between the cause and the consequence — is the change in gut microbiota composition the cause of the behavioural change or its consequence ?
5-1	495-497	In	_	_	_	_
5-2	498-506	addition	_	_	_	_
5-3	507-508	,	_	_	_	_
5-4	509-512	the	abstract[28]	new[28]	_	_
5-5	513-524	correlation	abstract|abstract[28]	giv|new[28]	_	_
5-6	525-533	analysis	abstract[28]	new[28]	_	_
5-7	534-540	cannot	_	_	_	_
5-8	541-552	distinguish	_	_	_	_
5-9	553-560	between	_	_	_	_
5-10	561-564	the	abstract[29]	new[29]	_	_
5-11	565-570	cause	abstract[29]	new[29]	_	_
5-12	571-574	and	_	_	_	_
5-13	575-578	the	abstract[30]	new[30]	coref	5-30[37_30]
5-14	579-590	consequence	abstract[30]	new[30]	_	_
5-15	591-592	—	_	_	_	_
5-16	593-595	is	_	_	_	_
5-17	596-599	the	abstract[31]	new[31]	coref	5-23[34_31]
5-18	600-606	change	abstract[31]	new[31]	_	_
5-19	607-609	in	abstract[31]	new[31]	_	_
5-20	610-613	gut	abstract[31]|abstract	new[31]|giv	coref	7-18
5-21	614-624	microbiota	abstract[31]|substance	new[31]|giv	coref	7-18[54_0]
5-22	625-636	composition	abstract[31]	new[31]	_	_
5-23	637-640	the	abstract[34]	giv[34]	ana	5-30[0_34]
5-24	641-646	cause	abstract[34]	giv[34]	_	_
5-25	647-649	of	abstract[34]	giv[34]	_	_
5-26	650-653	the	abstract[34]|event[35]	giv[34]|new[35]	_	_
5-27	654-665	behavioural	abstract[34]|event[35]	giv[34]|new[35]	_	_
5-28	666-672	change	abstract[34]|event[35]	giv[34]|new[35]	_	_
5-29	673-675	or	abstract[34]	giv[34]	_	_
5-30	676-679	its	abstract[34]|abstract|abstract[37]	giv[34]|giv|giv[37]	_	_
5-31	680-691	consequence	abstract[34]|abstract[37]	giv[34]|giv[37]	_	_
5-32	692-693	?	_	_	_	_

#Text=Studies administering defined bacteria , followed by verification of their presence in the intestinal tract and their association with tested characteristics , are much less frequent and most frequently involve the administration of Lactobacillaceae family members .
6-1	694-701	Studies	plant[38]	new[38]	ana	6-10[0_38]
6-2	702-715	administering	plant[38]	new[38]	_	_
6-3	716-723	defined	plant[38]|substance[39]	new[38]|new[39]	_	_
6-4	724-732	bacteria	plant[38]|substance[39]	new[38]|new[39]	_	_
6-5	733-734	,	plant[38]	new[38]	_	_
6-6	735-743	followed	plant[38]	new[38]	_	_
6-7	744-746	by	plant[38]	new[38]	_	_
6-8	747-759	verification	plant[38]|abstract[40]	new[38]|new[40]	_	_
6-9	760-762	of	plant[38]|abstract[40]	new[38]|new[40]	_	_
6-10	763-768	their	plant[38]|abstract[40]|plant|abstract[42]	new[38]|new[40]|giv|new[42]	ana	6-17
6-11	769-777	presence	plant[38]|abstract[40]|abstract[42]	new[38]|new[40]|new[42]	_	_
6-12	778-780	in	plant[38]|abstract[40]|abstract[42]	new[38]|new[40]|new[42]	_	_
6-13	781-784	the	plant[38]|abstract[40]|abstract[42]|object[43]	new[38]|new[40]|new[42]|new[43]	coref	7-25[56_43]
6-14	785-795	intestinal	plant[38]|abstract[40]|abstract[42]|object[43]	new[38]|new[40]|new[42]|new[43]	_	_
6-15	796-801	tract	plant[38]|abstract[40]|abstract[42]|object[43]	new[38]|new[40]|new[42]|new[43]	_	_
6-16	802-805	and	plant[38]|abstract[40]	new[38]|new[40]	_	_
6-17	806-811	their	plant[38]|abstract[40]|plant|abstract[45]	new[38]|new[40]|giv|new[45]	_	_
6-18	812-823	association	plant[38]|abstract[40]|abstract[45]	new[38]|new[40]|new[45]	_	_
6-19	824-828	with	plant[38]|abstract[40]|abstract[45]	new[38]|new[40]|new[45]	_	_
6-20	829-835	tested	plant[38]|abstract[40]|abstract[45]|abstract[46]	new[38]|new[40]|new[45]|new[46]	_	_
6-21	836-851	characteristics	plant[38]|abstract[40]|abstract[45]|abstract[46]	new[38]|new[40]|new[45]|new[46]	_	_
6-22	852-853	,	_	_	_	_
6-23	854-857	are	_	_	_	_
6-24	858-862	much	_	_	_	_
6-25	863-867	less	_	_	_	_
6-26	868-876	frequent	_	_	_	_
6-27	877-880	and	_	_	_	_
6-28	881-885	most	_	_	_	_
6-29	886-896	frequently	_	_	_	_
6-30	897-904	involve	_	_	_	_
6-31	905-908	the	event[47]	new[47]	_	_
6-32	909-923	administration	event[47]	new[47]	_	_
6-33	924-926	of	event[47]	new[47]	_	_
6-34	927-943	Lactobacillaceae	event[47]|event|animal[50]	new[47]|new|new[50]	coref	14-36[118_50]
6-35	944-950	family	event[47]|organization|animal[50]	new[47]|new|new[50]	_	_
6-36	951-958	members	event[47]|animal[50]	new[47]|new[50]	_	_
6-37	959-960	.	_	_	_	_

#Text=However , Lactobacillaceae , though common in the small intestine , form only a small fraction of gut microbiota in the distal parts of the intestinal tract like the caecum , microbiota of which is formed by hundreds of anaerobic bacterial species different from Lactobacilli .
7-1	961-968	However	_	_	_	_
7-2	969-970	,	_	_	_	_
7-3	971-987	Lactobacillaceae	_	_	_	_
7-4	988-989	,	_	_	_	_
7-5	990-996	though	_	_	_	_
7-6	997-1003	common	_	_	_	_
7-7	1004-1006	in	_	_	_	_
7-8	1007-1010	the	place[51]	new[51]	_	_
7-9	1011-1016	small	place[51]	new[51]	_	_
7-10	1017-1026	intestine	place[51]	new[51]	_	_
7-11	1027-1028	,	_	_	_	_
7-12	1029-1033	form	_	_	_	_
7-13	1034-1038	only	abstract[52]	new[52]	_	_
7-14	1039-1040	a	abstract[52]	new[52]	_	_
7-15	1041-1046	small	abstract[52]	new[52]	_	_
7-16	1047-1055	fraction	abstract[52]	new[52]	_	_
7-17	1056-1058	of	abstract[52]	new[52]	_	_
7-18	1059-1062	gut	abstract[52]|abstract|substance[54]	new[52]|giv|giv[54]	coref|coref	7-32[58_54]|8-13
7-19	1063-1073	microbiota	abstract[52]|substance[54]	new[52]|giv[54]	_	_
7-20	1074-1076	in	abstract[52]|substance[54]	new[52]|giv[54]	_	_
7-21	1077-1080	the	abstract[52]|substance[54]|abstract[55]	new[52]|giv[54]|new[55]	_	_
7-22	1081-1087	distal	abstract[52]|substance[54]|abstract[55]	new[52]|giv[54]|new[55]	_	_
7-23	1088-1093	parts	abstract[52]|substance[54]|abstract[55]	new[52]|giv[54]|new[55]	_	_
7-24	1094-1096	of	abstract[52]|substance[54]|abstract[55]	new[52]|giv[54]|new[55]	_	_
7-25	1097-1100	the	abstract[52]|substance[54]|abstract[55]|object[56]	new[52]|giv[54]|new[55]|giv[56]	coref	9-26[80_56]
7-26	1101-1111	intestinal	abstract[52]|substance[54]|abstract[55]|object[56]	new[52]|giv[54]|new[55]|giv[56]	_	_
7-27	1112-1117	tract	abstract[52]|substance[54]|abstract[55]|object[56]	new[52]|giv[54]|new[55]|giv[56]	_	_
7-28	1118-1122	like	abstract[52]|substance[54]|abstract[55]|object[56]	new[52]|giv[54]|new[55]|giv[56]	_	_
7-29	1123-1126	the	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]	new[52]|giv[54]|new[55]|giv[56]|new[57]	coref	15-20[130_57]
7-30	1127-1133	caecum	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]	new[52]|giv[54]|new[55]|giv[56]|new[57]	_	_
7-31	1134-1135	,	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]	new[52]|giv[54]|new[55]|giv[56]|new[57]	_	_
7-32	1136-1146	microbiota	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|substance[58]	new[52]|giv[54]|new[55]|giv[56]|new[57]|giv[58]	coref	12-11[97_58]
7-33	1147-1149	of	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|substance[58]	new[52]|giv[54]|new[55]|giv[56]|new[57]|giv[58]	_	_
7-34	1150-1155	which	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|substance[58]	new[52]|giv[54]|new[55]|giv[56]|new[57]|giv[58]	_	_
7-35	1156-1158	is	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]	new[52]|giv[54]|new[55]|giv[56]|new[57]	_	_
7-36	1159-1165	formed	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]	new[52]|giv[54]|new[55]|giv[56]|new[57]	_	_
7-37	1166-1168	by	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]	new[52]|giv[54]|new[55]|giv[56]|new[57]	_	_
7-38	1169-1177	hundreds	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|animal[59]	new[52]|giv[54]|new[55]|giv[56]|new[57]|new[59]	coref	14-8[108_59]
7-39	1178-1180	of	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|animal[59]	new[52]|giv[54]|new[55]|giv[56]|new[57]|new[59]	_	_
7-40	1181-1190	anaerobic	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|animal[59]	new[52]|giv[54]|new[55]|giv[56]|new[57]|new[59]	_	_
7-41	1191-1200	bacterial	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|animal[59]	new[52]|giv[54]|new[55]|giv[56]|new[57]|new[59]	_	_
7-42	1201-1208	species	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|animal[59]	new[52]|giv[54]|new[55]|giv[56]|new[57]|new[59]	_	_
7-43	1209-1218	different	abstract[52]|substance[54]|abstract[55]|object[56]|plant[57]|animal[59]	new[52]|giv[54]|new[55]|giv[56]|new[57]|new[59]	_	_
7-44	1219-1223	from	_	_	_	_
7-45	1224-1236	Lactobacilli	person	new	_	_
7-46	1237-1238	.	_	_	_	_

#Text=Because of this , we and others have initiated systematic culturing of gut anaerobes to have them available for whole genome sequencing and subsequent experiments .
8-1	1239-1246	Because	_	_	_	_
8-2	1247-1249	of	_	_	_	_
8-3	1250-1254	this	_	_	_	_
8-4	1255-1256	,	_	_	_	_
8-5	1257-1259	we	person	acc	ana	9-3
8-6	1260-1263	and	_	_	_	_
8-7	1264-1270	others	person	new	ana	8-17
8-8	1271-1275	have	_	_	_	_
8-9	1276-1285	initiated	_	_	_	_
8-10	1286-1296	systematic	time[63]	new[63]	_	_
8-11	1297-1306	culturing	time[63]	new[63]	_	_
8-12	1307-1309	of	time[63]	new[63]	_	_
8-13	1310-1313	gut	time[63]|abstract|animal[65]	new[63]|giv|new[65]	coref|coref	9-11|9-10[74_65]
8-14	1314-1323	anaerobes	time[63]|animal[65]	new[63]|new[65]	_	_
8-15	1324-1326	to	_	_	_	_
8-16	1327-1331	have	_	_	_	_
8-17	1332-1336	them	person	giv	_	_
8-18	1337-1346	available	_	_	_	_
8-19	1347-1350	for	_	_	_	_
8-20	1351-1356	whole	abstract[67]|abstract[68]	new[67]|giv[68]	_	_
8-21	1357-1363	genome	abstract[67]|abstract[68]	new[67]|giv[68]	_	_
8-22	1364-1374	sequencing	abstract[68]	giv[68]	_	_
8-23	1375-1378	and	_	_	_	_
8-24	1379-1389	subsequent	event[69]	new[69]	_	_
8-25	1390-1401	experiments	event[69]	new[69]	_	_
8-26	1402-1403	.	_	_	_	_

#Text=Soon after we formed an initial laboratory collection of chicken gut anaerobes , we compared the isolates from the collection with those commonly found in chicken intestinal tract .
9-1	1404-1408	Soon	_	_	_	_
9-2	1409-1414	after	_	_	_	_
9-3	1415-1417	we	person	giv	ana	9-14
9-4	1418-1424	formed	_	_	_	_
9-5	1425-1427	an	object[71]	new[71]	coref	9-19[77_71]
9-6	1428-1435	initial	object[71]	new[71]	_	_
9-7	1436-1446	laboratory	object[71]	new[71]	_	_
9-8	1447-1457	collection	object[71]	new[71]	_	_
9-9	1458-1460	of	object[71]	new[71]	_	_
9-10	1461-1468	chicken	object[71]|animal|animal[74]	new[71]|new|giv[74]	coref|coref	9-26|10-11[84_74]
9-11	1469-1472	gut	object[71]|abstract|animal[74]	new[71]|giv|giv[74]	coref	10-12[83_0]
9-12	1473-1482	anaerobes	object[71]|animal[74]	new[71]|giv[74]	_	_
9-13	1483-1484	,	_	_	_	_
9-14	1485-1487	we	person	giv	ana	10-5
9-15	1488-1496	compared	_	_	_	_
9-16	1497-1500	the	substance[76]	new[76]	_	_
9-17	1501-1509	isolates	substance[76]	new[76]	_	_
9-18	1510-1514	from	substance[76]	new[76]	_	_
9-19	1515-1518	the	substance[76]|object[77]	new[76]|giv[77]	ana	9-22[78_77]
9-20	1519-1529	collection	substance[76]|object[77]	new[76]|giv[77]	_	_
9-21	1530-1534	with	_	_	_	_
9-22	1535-1540	those	object[78]	giv[78]	_	_
9-23	1541-1549	commonly	object[78]	giv[78]	_	_
9-24	1550-1555	found	object[78]	giv[78]	_	_
9-25	1556-1558	in	object[78]	giv[78]	_	_
9-26	1559-1566	chicken	object[78]|animal|object[80]	giv[78]|giv|giv[80]	coref	10-12
9-27	1567-1577	intestinal	object[78]|object[80]	giv[78]|giv[80]	_	_
9-28	1578-1583	tract	object[78]|object[80]	giv[78]|giv[80]	_	_
9-29	1584-1585	.	_	_	_	_

#Text=In other words , we were interested whether there were any chicken gut anaerobes which were difficult to culture .
10-1	1586-1588	In	_	_	_	_
10-2	1589-1594	other	_	_	_	_
10-3	1595-1600	words	_	_	_	_
10-4	1601-1602	,	_	_	_	_
10-5	1603-1605	we	person	giv	ana	14-54
10-6	1606-1610	were	_	_	_	_
10-7	1611-1621	interested	_	_	_	_
10-8	1622-1629	whether	_	_	_	_
10-9	1630-1635	there	_	_	_	_
10-10	1636-1640	were	_	_	_	_
10-11	1641-1644	any	animal[84]	giv[84]	_	_
10-12	1645-1652	chicken	animal|abstract[83]|animal[84]	giv|giv[83]|giv[84]	coref|coref	12-12[0_83]|15-21
10-13	1653-1656	gut	abstract[83]|animal[84]	giv[83]|giv[84]	_	_
10-14	1657-1666	anaerobes	animal[84]	giv[84]	_	_
10-15	1667-1672	which	animal[84]	giv[84]	_	_
10-16	1673-1677	were	animal[84]	giv[84]	_	_
10-17	1678-1687	difficult	animal[84]	giv[84]	_	_
10-18	1688-1690	to	animal[84]	giv[84]	_	_
10-19	1691-1698	culture	animal[84]	giv[84]	_	_
10-20	1699-1700	.	_	_	_	_

#Text=Other studies addressed the same question by comparing the bacterial composition in original faecal or caecal samples with those in nutrient broth after culture .
11-1	1701-1706	Other	abstract[85]	giv[85]	coref	12-1[94_85]
11-2	1707-1714	studies	abstract[85]	giv[85]	_	_
11-3	1715-1724	addressed	_	_	_	_
11-4	1725-1728	the	abstract[86]	new[86]	ana	11-19[90_86]
11-5	1729-1733	same	abstract[86]	new[86]	_	_
11-6	1734-1742	question	abstract[86]	new[86]	_	_
11-7	1743-1745	by	_	_	_	_
11-8	1746-1755	comparing	_	_	_	_
11-9	1756-1759	the	abstract[87]	giv[87]	_	_
11-10	1760-1769	bacterial	abstract[87]	giv[87]	_	_
11-11	1770-1781	composition	abstract[87]	giv[87]	_	_
11-12	1782-1784	in	abstract[87]	giv[87]	_	_
11-13	1785-1793	original	abstract[87]|object[89]	giv[87]|new[89]	_	_
11-14	1794-1800	faecal	abstract[87]|substance|object[89]	giv[87]|new|new[89]	_	_
11-15	1801-1803	or	abstract[87]|object[89]	giv[87]|new[89]	_	_
11-16	1804-1810	caecal	abstract[87]|object[89]	giv[87]|new[89]	_	_
11-17	1811-1818	samples	abstract[87]|object[89]	giv[87]|new[89]	_	_
11-18	1819-1823	with	_	_	_	_
11-19	1824-1829	those	abstract[90]	giv[90]	_	_
11-20	1830-1832	in	abstract[90]	giv[90]	_	_
11-21	1833-1841	nutrient	abstract[90]|substance|substance[92]	giv[90]|new|new[92]	_	_
11-22	1842-1847	broth	abstract[90]|substance[92]	giv[90]|new[92]	_	_
11-23	1848-1853	after	abstract[90]	giv[90]	_	_
11-24	1854-1861	culture	abstract[90]|abstract	giv[90]|new	coref	12-22
11-25	1862-1863	.	_	_	_	_

#Text=These studies concluded that between 50 to 90 % of total gut microbiota could be cultured in vitro if the appropriate culture conditions are provided .
12-1	1864-1869	These	abstract[94]	giv[94]	coref	13-3[101_94]
12-2	1870-1877	studies	abstract[94]	giv[94]	_	_
12-3	1878-1887	concluded	_	_	_	_
12-4	1888-1892	that	_	_	_	_
12-5	1893-1900	between	_	_	_	_
12-6	1901-1903	50	abstract[95]	new[95]	_	_
12-7	1904-1906	to	abstract[95]	new[95]	_	_
12-8	1907-1909	90	abstract[95]	new[95]	_	_
12-9	1910-1911	%	abstract[95]	new[95]	_	_
12-10	1912-1914	of	abstract[95]	new[95]	_	_
12-11	1915-1920	total	abstract[95]|substance[97]	new[95]|giv[97]	coref	14-37[0_97]
12-12	1921-1924	gut	abstract[95]|abstract|substance[97]	new[95]|giv|giv[97]	_	_
12-13	1925-1935	microbiota	abstract[95]|substance[97]	new[95]|giv[97]	_	_
12-14	1936-1941	could	_	_	_	_
12-15	1942-1944	be	_	_	_	_
12-16	1945-1953	cultured	_	_	_	_
12-17	1954-1956	in	_	_	_	_
12-18	1957-1962	vitro	organization	new	coref	13-23
12-19	1963-1965	if	_	_	_	_
12-20	1966-1969	the	abstract[100]	new[100]	coref	15-6[126_100]
12-21	1970-1981	appropriate	abstract[100]	new[100]	_	_
12-22	1982-1989	culture	abstract|abstract[100]	giv|new[100]	coref	15-7
12-23	1990-2000	conditions	abstract[100]	new[100]	_	_
12-24	2001-2004	are	_	_	_	_
12-25	2005-2013	provided	_	_	_	_
12-26	2014-2015	.	_	_	_	_

#Text=Unfortunately , these studies did not perform phylogenetic analyses of the OTUs ( operational taxonomic units ) capable or incapable of in vitro growth .
13-1	2016-2029	Unfortunately	_	_	_	_
13-2	2030-2031	,	_	_	_	_
13-3	2032-2037	these	abstract[101]	giv[101]	_	_
13-4	2038-2045	studies	abstract[101]	giv[101]	_	_
13-5	2046-2049	did	_	_	_	_
13-6	2050-2053	not	_	_	_	_
13-7	2054-2061	perform	_	_	_	_
13-8	2062-2074	phylogenetic	abstract[102]	giv[102]	_	_
13-9	2075-2083	analyses	abstract[102]	giv[102]	_	_
13-10	2084-2086	of	abstract[102]	giv[102]	_	_
13-11	2087-2090	the	abstract[102]|abstract[103]	giv[102]|new[103]	appos	13-14[104_103]
13-12	2091-2095	OTUs	abstract[102]|abstract[103]	giv[102]|new[103]	_	_
13-13	2096-2097	(	_	_	_	_
13-14	2098-2109	operational	abstract[104]	giv[104]	_	_
13-15	2110-2119	taxonomic	abstract[104]	giv[104]	_	_
13-16	2120-2125	units	abstract[104]	giv[104]	_	_
13-17	2126-2127	)	_	_	_	_
13-18	2128-2135	capable	_	_	_	_
13-19	2136-2138	or	_	_	_	_
13-20	2139-2148	incapable	_	_	_	_
13-21	2149-2151	of	_	_	_	_
13-22	2152-2154	in	_	_	_	_
13-23	2155-2160	vitro	organization|abstract[106]	giv|new[106]	ana|coref	14-3[0_106]|14-13[109_0]
13-24	2161-2167	growth	abstract[106]	new[106]	_	_
13-25	2168-2169	.	_	_	_	_

#Text=Therefore , it is not known whether the bacterial species resistant to in vitro growth are randomly distributed among known bacterial phyla , classes , orders , families , genera or species , or whether the microbiota members resistant to in vitro growth are clustered in particular lineages , which is exactly what we investigated in this study .
14-1	2170-2179	Therefore	_	_	_	_
14-2	2180-2181	,	_	_	_	_
14-3	2182-2184	it	abstract	giv	coref	14-13[110_0]
14-4	2185-2187	is	_	_	_	_
14-5	2188-2191	not	_	_	_	_
14-6	2192-2197	known	_	_	_	_
14-7	2198-2205	whether	_	_	_	_
14-8	2206-2209	the	animal[108]	giv[108]	coref	14-32[0_108]
14-9	2210-2219	bacterial	animal[108]	giv[108]	_	_
14-10	2220-2227	species	animal[108]	giv[108]	_	_
14-11	2228-2237	resistant	animal[108]	giv[108]	_	_
14-12	2238-2240	to	animal[108]	giv[108]	_	_
14-13	2241-2243	in	animal[108]|organization[109]|abstract[110]	giv[108]|giv[109]|giv[110]	coref|coref	14-41[119_109]|14-41[120_110]
14-14	2244-2249	vitro	animal[108]|organization[109]|abstract[110]	giv[108]|giv[109]|giv[110]	_	_
14-15	2250-2256	growth	animal[108]|abstract[110]	giv[108]|giv[110]	_	_
14-16	2257-2260	are	_	_	_	_
14-17	2261-2269	randomly	_	_	_	_
14-18	2270-2281	distributed	_	_	_	_
14-19	2282-2287	among	_	_	_	_
14-20	2288-2293	known	abstract[111]	new[111]	_	_
14-21	2294-2303	bacterial	abstract[111]	new[111]	_	_
14-22	2304-2309	phyla	abstract[111]	new[111]	_	_
14-23	2310-2311	,	_	_	_	_
14-24	2312-2319	classes	abstract	new	_	_
14-25	2320-2321	,	_	_	_	_
14-26	2322-2328	orders	abstract	new	_	_
14-27	2329-2330	,	_	_	_	_
14-28	2331-2339	families	abstract	new	_	_
14-29	2340-2341	,	_	_	_	_
14-30	2342-2348	genera	abstract	new	_	_
14-31	2349-2351	or	_	_	_	_
14-32	2352-2359	species	animal	giv	_	_
14-33	2360-2361	,	_	_	_	_
14-34	2362-2364	or	_	_	_	_
14-35	2365-2372	whether	_	_	_	_
14-36	2373-2376	the	animal[118]	giv[118]	coref	17-11[149_118]
14-37	2377-2387	microbiota	substance|animal[118]	giv|giv[118]	coref	17-12
14-38	2388-2395	members	animal[118]	giv[118]	_	_
14-39	2396-2405	resistant	animal[118]	giv[118]	_	_
14-40	2406-2408	to	animal[118]	giv[118]	_	_
14-41	2409-2411	in	animal[118]|organization[119]|abstract[120]	giv[118]|giv[119]|giv[120]	coref|coref	15-29[0_119]|16-29[141_120]
14-42	2412-2417	vitro	animal[118]|organization[119]|abstract[120]	giv[118]|giv[119]|giv[120]	_	_
14-43	2418-2424	growth	animal[118]|abstract[120]	giv[118]|giv[120]	_	_
14-44	2425-2428	are	_	_	_	_
14-45	2429-2438	clustered	_	_	_	_
14-46	2439-2441	in	_	_	_	_
14-47	2442-2452	particular	abstract[121]	new[121]	coref	15-16[128_121]
14-48	2453-2461	lineages	abstract[121]	new[121]	_	_
14-49	2462-2463	,	_	_	_	_
14-50	2464-2469	which	_	_	_	_
14-51	2470-2472	is	_	_	_	_
14-52	2473-2480	exactly	_	_	_	_
14-53	2481-2485	what	_	_	_	_
14-54	2486-2488	we	person	giv	ana	16-8
14-55	2489-2501	investigated	_	_	_	_
14-56	2502-2504	in	_	_	_	_
14-57	2505-2509	this	abstract[123]	new[123]	_	_
14-58	2510-2515	study	abstract[123]	new[123]	_	_
14-59	2516-2517	.	_	_	_	_

#Text=Using a larger set of different culture conditions , the primary aim was to determine which bacterial lineages colonising the chicken caecum have not yet been cultured in vitro .
15-1	2518-2523	Using	_	_	_	_
15-2	2524-2525	a	abstract[124]	new[124]	_	_
15-3	2526-2532	larger	abstract[124]	new[124]	_	_
15-4	2533-2536	set	abstract[124]	new[124]	_	_
15-5	2537-2539	of	abstract[124]	new[124]	_	_
15-6	2540-2549	different	abstract[124]|abstract[126]	new[124]|giv[126]	coref	16-38[144_126]
15-7	2550-2557	culture	abstract[124]|abstract|abstract[126]	new[124]|giv|giv[126]	coref	16-41
15-8	2558-2568	conditions	abstract[124]|abstract[126]	new[124]|giv[126]	_	_
15-9	2569-2570	,	_	_	_	_
15-10	2571-2574	the	abstract[127]	new[127]	_	_
15-11	2575-2582	primary	abstract[127]	new[127]	_	_
15-12	2583-2586	aim	abstract[127]	new[127]	_	_
15-13	2587-2590	was	_	_	_	_
15-14	2591-2593	to	_	_	_	_
15-15	2594-2603	determine	_	_	_	_
15-16	2604-2609	which	abstract[128]	giv[128]	_	_
15-17	2610-2619	bacterial	abstract[128]	giv[128]	_	_
15-18	2620-2628	lineages	abstract[128]	giv[128]	_	_
15-19	2629-2639	colonising	abstract[128]	giv[128]	_	_
15-20	2640-2643	the	abstract[128]|plant[130]	giv[128]|giv[130]	_	_
15-21	2644-2651	chicken	abstract[128]|animal|plant[130]	giv[128]|giv|giv[130]	_	_
15-22	2652-2658	caecum	abstract[128]|plant[130]	giv[128]|giv[130]	_	_
15-23	2659-2663	have	_	_	_	_
15-24	2664-2667	not	_	_	_	_
15-25	2668-2671	yet	_	_	_	_
15-26	2672-2676	been	_	_	_	_
15-27	2677-2685	cultured	_	_	_	_
15-28	2686-2688	in	_	_	_	_
15-29	2689-2694	vitro	organization	giv	_	_
15-30	2695-2696	.	_	_	_	_

#Text=Furthermore , the experimental design also enabled us to address secondary aims such as to which extent feed or food additives , therapeutics or drugs influence in vitro bacterial growth in complex microbial populations and what are the most selective culture conditions for particular taxa .
16-1	2697-2708	Furthermore	_	_	_	_
16-2	2709-2710	,	_	_	_	_
16-3	2711-2714	the	abstract[132]	new[132]	_	_
16-4	2715-2727	experimental	abstract[132]	new[132]	_	_
16-5	2728-2734	design	abstract[132]	new[132]	_	_
16-6	2735-2739	also	_	_	_	_
16-7	2740-2747	enabled	_	_	_	_
16-8	2748-2750	us	person	giv	_	_
16-9	2751-2753	to	_	_	_	_
16-10	2754-2761	address	_	_	_	_
16-11	2762-2771	secondary	abstract[134]	new[134]	_	_
16-12	2772-2776	aims	abstract[134]	new[134]	_	_
16-13	2777-2781	such	abstract[134]	new[134]	_	_
16-14	2782-2784	as	abstract[134]	new[134]	_	_
16-15	2785-2787	to	abstract[134]	new[134]	_	_
16-16	2788-2793	which	abstract[134]|abstract[135]	new[134]|new[135]	_	_
16-17	2794-2800	extent	abstract[134]|abstract[135]	new[134]|new[135]	_	_
16-18	2801-2805	feed	abstract[134]|substance	new[134]|new	_	_
16-19	2806-2808	or	abstract[134]	new[134]	_	_
16-20	2809-2813	food	abstract[134]|substance	new[134]|new	_	_
16-21	2814-2823	additives	abstract[134]|substance	new[134]|new	_	_
16-22	2824-2825	,	abstract[134]	new[134]	_	_
16-23	2826-2838	therapeutics	abstract[134]|substance	new[134]|new	_	_
16-24	2839-2841	or	abstract[134]	new[134]	_	_
16-25	2842-2847	drugs	abstract[134]|substance	new[134]|new	_	_
16-26	2848-2857	influence	abstract[134]	new[134]	_	_
16-27	2858-2860	in	abstract[134]	new[134]	_	_
16-28	2861-2866	vitro	abstract[134]	new[134]	_	_
16-29	2867-2876	bacterial	abstract[134]|abstract[141]	new[134]|giv[141]	_	_
16-30	2877-2883	growth	abstract[134]|abstract[141]	new[134]|giv[141]	_	_
16-31	2884-2886	in	abstract[134]|abstract[141]	new[134]|giv[141]	_	_
16-32	2887-2894	complex	abstract[134]|abstract[141]|abstract[142]	new[134]|giv[141]|new[142]	_	_
16-33	2895-2904	microbial	abstract[134]|abstract[141]|abstract[142]	new[134]|giv[141]|new[142]	_	_
16-34	2905-2916	populations	abstract[134]|abstract[141]|abstract[142]	new[134]|giv[141]|new[142]	_	_
16-35	2917-2920	and	abstract[134]	new[134]	_	_
16-36	2921-2925	what	abstract[134]	new[134]	_	_
16-37	2926-2929	are	abstract[134]	new[134]	_	_
16-38	2930-2933	the	abstract[134]|abstract[144]	new[134]|giv[144]	_	_
16-39	2934-2938	most	abstract[134]|abstract[144]	new[134]|giv[144]	_	_
16-40	2939-2948	selective	abstract[134]|abstract[144]	new[134]|giv[144]	_	_
16-41	2949-2956	culture	abstract[134]|abstract|abstract[144]	new[134]|giv|giv[144]	_	_
16-42	2957-2967	conditions	abstract[134]|abstract[144]	new[134]|giv[144]	_	_
16-43	2968-2971	for	abstract[134]|abstract[144]	new[134]|giv[144]	_	_
16-44	2972-2982	particular	abstract[134]|abstract[144]|animal[145]	new[134]|giv[144]|new[145]	_	_
16-45	2983-2987	taxa	abstract[134]|abstract[144]|animal[145]	new[134]|giv[144]|new[145]	_	_
16-46	2988-2989	.	_	_	_	_

#Text=Indirectly , such data also points towards possible functions of individual microbiota members in vivo .
17-1	2990-3000	Indirectly	_	_	_	_
17-2	3001-3002	,	_	_	_	_
17-3	3003-3007	such	abstract[146]	giv[146]	_	_
17-4	3008-3012	data	abstract[146]	giv[146]	_	_
17-5	3013-3017	also	_	_	_	_
17-6	3018-3024	points	_	_	_	_
17-7	3025-3032	towards	_	_	_	_
17-8	3033-3041	possible	abstract[147]	new[147]	_	_
17-9	3042-3051	functions	abstract[147]	new[147]	_	_
17-10	3052-3054	of	abstract[147]	new[147]	_	_
17-11	3055-3065	individual	abstract[147]|animal[149]	new[147]|giv[149]	_	_
17-12	3066-3076	microbiota	abstract[147]|substance|animal[149]	new[147]|giv|giv[149]	_	_
17-13	3077-3084	members	abstract[147]|animal[149]	new[147]|giv[149]	_	_
17-14	3085-3087	in	_	_	_	_
17-15	3088-3092	vivo	abstract	new	_	_
17-16	3093-3094	.	_	_	_	_
